Metropolis Healthcare Ltd.'s bottom line rose 19% during the first quarter of current financial year 2025-26.
The healthcare service provider's net profit surged to Rs 45.06 crore during the April-June period, against Rs 37.95 crore for the year-ago period, according to an exchange filing on Thursday.
Metropolis Q1 FY26 Highlights (Consolidated, YoY)
Revenue up 23.2% to Rs 386.06 crore versus Rs 313.36 crore.
Net profit up 19% to Rs 45.06 crore versus Rs 37.95 crore.
Ebitda up 14% to Rs 89.76 crore versus Rs 78.81 crore.
Margin at 23.3% versus 25.1%.
Shares of Metropolis Healthcare closed 2.97% lower at Rs 1,994.6 apiece on the NSE, compared to a 0.09% rise in the benchmark Nifty. The stock has fallen 5.21% in the last 12 months and 3.95% on a year-to-date basis.
Out of the 24 analysts tracking the company, 17 have a 'buy' rating on the stock, two recommend 'hold' and five gave 'sell', according to Bloomberg data. The average of 12-month analysts' price targets implies a potential downside of 2.5%.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
